(Q58235826)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826112%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826112%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

0 references

1 reference

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826112%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826112%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826112%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Man-Fung Yuen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826112%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

John Yuen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826112%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

John Young

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826112%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Danny Ka-Ho Wong

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826112%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

language of work or name

English

0 references

publication date

9 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826112%20AND%20SRC:MED&resulttype=core&format=json

The American Journal of Gastroenterology

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826112%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826112%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826112%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

1766-1773

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826112%20AND%20SRC:MED&resulttype=core&format=json

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.253

Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.253

On-treatment monitoring of adefovir therapy in chronic hepatitis B: virologic response can be assessed at 24 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.253

A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.253

Chronic hepatitis B: update 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.253

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.253

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.253

A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.253

Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.253

Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.253

Comparison between quantitative hepatitis B surface antigen, hepatitis B e-antigen and hepatitis B virus DNA levels for predicting virological response to pegylated interferon-α-2b therapy in hepatitis B e-antigen-positive chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.253

Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.253

Serum HBsAg changes in HBeAg positive chronic hepatitis B patients with continuous viral load reductions during treatment with adefovir or peg-interferon-alpha-2a

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.253

Change in serum hepatitis B surface antigen level and its clinical significance in treatment-naïve, hepatitis B e antigen-positive patients receiving entecavir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.253

Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.253

Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.253

Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.253

Hepatitis B surface antigen: Relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.253

21 January 2018

Identifiers

DOI

10.1038/AJG.2011.253

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826112%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21826112%20AND%20SRC:MED&resulttype=core&format=json